322 related articles for article (PubMed ID: 22045495)
1. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.
Dong H; Murphy KM; Meng L; Montalvo-Ortiz J; Zeng Z; Kolber BJ; Zhang S; Muglia LJ; Csernansky JG
J Alzheimers Dis; 2012; 28(3):579-92. PubMed ID: 22045495
[TBL] [Abstract][Full Text] [Related]
2. Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.
Dong H; Wang S; Zeng Z; Li F; Montalvo-Ortiz J; Tucker C; Akhtar S; Shi J; Meltzer HY; Rice KC; Csernansky JG
Psychopharmacology (Berl); 2014 Dec; 231(24):4711-22. PubMed ID: 24862368
[TBL] [Abstract][Full Text] [Related]
3. Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice.
Dong H; Yuede CM; Yoo HS; Martin MV; Deal C; Mace AG; Csernansky JG
Neuroscience; 2008 Jul; 155(1):154-63. PubMed ID: 18571864
[TBL] [Abstract][Full Text] [Related]
4. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
[TBL] [Abstract][Full Text] [Related]
5. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
[TBL] [Abstract][Full Text] [Related]
6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
7. Transient early-life forebrain corticotropin-releasing hormone elevation causes long-lasting anxiogenic and despair-like changes in mice.
Kolber BJ; Boyle MP; Wieczorek L; Kelley CL; Onwuzurike CC; Nettles SA; Vogt SK; Muglia LJ
J Neurosci; 2010 Feb; 30(7):2571-81. PubMed ID: 20164342
[TBL] [Abstract][Full Text] [Related]
8. Forebrain CRF₁ modulates early-life stress-programmed cognitive deficits.
Wang XD; Rammes G; Kraev I; Wolf M; Liebl C; Scharf SH; Rice CJ; Wurst W; Holsboer F; Deussing JM; Baram TZ; Stewart MG; Müller MB; Schmidt MV
J Neurosci; 2011 Sep; 31(38):13625-34. PubMed ID: 21940453
[TBL] [Abstract][Full Text] [Related]
9. Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.
Fowler SW; Chiang AC; Savjani RR; Larson ME; Sherman MA; Schuler DR; Cirrito JR; Lesné SE; Jankowsky JL
J Neurosci; 2014 Jun; 34(23):7871-85. PubMed ID: 24899710
[TBL] [Abstract][Full Text] [Related]
10. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.
Havas D; Hutter-Paier B; Ubhi K; Rockenstein E; Crailsheim K; Masliah E; Windisch M
J Alzheimers Dis; 2011; 25(2):231-43. PubMed ID: 21403389
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease.
Richard KL; Filali M; Préfontaine P; Rivest S
J Neurosci; 2008 May; 28(22):5784-93. PubMed ID: 18509040
[TBL] [Abstract][Full Text] [Related]
14. Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Aβ and pTau in a mouse model of Alzheimer's disease.
Rothman SM; Herdener N; Frankola KA; Mughal MR; Mattson MP
Brain Res; 2013 Sep; 1529():200-8. PubMed ID: 23856323
[TBL] [Abstract][Full Text] [Related]
15. Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis.
Melnikova T; Fromholt S; Kim H; Lee D; Xu G; Price A; Moore BD; Golde TE; Felsenstein KM; Savonenko A; Borchelt DR
J Neurosci; 2013 Feb; 33(9):3765-79. PubMed ID: 23447589
[TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.
Dumont M; Kipiani K; Yu F; Wille E; Katz M; Calingasan NY; Gouras GK; Lin MT; Beal MF
J Alzheimers Dis; 2011; 27(1):211-23. PubMed ID: 21799249
[TBL] [Abstract][Full Text] [Related]
17. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
18. Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1).
Giusti-Rodríguez P; Gao J; Gräff J; Rei D; Soda T; Tsai LH
J Neurosci; 2011 Nov; 31(44):15751-6. PubMed ID: 22049418
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile.
Liu P; Paulson JB; Forster CL; Shapiro SL; Ashe KH; Zahs KR
PLoS One; 2015; 10(5):e0126317. PubMed ID: 25946042
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
